Mike Royal

2013

In 2013, Mike Royal earned a total compensation of $293.9K as Former EVP, Clinical and Regulatory Affairs at Sorrento Therapeutics.

Compensation breakdown

Option Awards$205,560
Salary$84,792
Other$3,520
Total$293,871

Royal received $205.6K in option awards, accounting for 70% of the total pay in 2013.

Royal also received $84.8K in salary and $3.5K in other compensation.

Rankings

In 2013, Mike Royal's compensation ranked 10,891st out of 12,286 executives tracked by ExecPay. In other words, Royal earned more than 11.4% of executives.

ClassificationRankingPercentile
All
10,891
out of 12,286
11th
Division
Manufacturing
4,074
out of 4,612
12th
Major group
Chemicals And Allied Products
1,289
out of 1,462
12th
Industry group
Drugs
1,017
out of 1,156
12th
Industry
Biological Products, Except Diagnostic Substances
166
out of 196
15th
Source: SEC filing on May 13, 2016.

Royal's colleagues

We found four more compensation records of executives who worked with Mike Royal at Sorrento Therapeutics in 2013.

2013

Henry Ji

Sorrento Therapeutics

Chief Executive Officer

2013

Richard Vincent

Sorrento Therapeutics

Chief Financial Officer

2013

David Miao

Sorrento Therapeutics

Former SVP, Head of ADC Development

2013

George Uy

Sorrento Therapeutics

EVP and Chief Commercial Officer

In-depth

You may also like